SIR, Takayasu arteritis (TA) is a chronic, idiopathic, inflammatory disease that primarily
affects large vessels [1]. The management of this disorder is largely unresolved, since a …

Objective To report a single‐center experience with the use of tumor necrosis factor (TNF)
inhibitors in patients with Takayasu arteritis (TA). Methods We retrospectively studied a …

Objective: To assess the efficacy of anti-tumour necrosis factor (TNF) therapy to induce
remission in patients with Takayasu arteritis (TAK) refractory to other immunosuppressive …

Objective To test the efficacy of Infliximab, a chimeric monoclonal antibody against TNF-α, in
the treatment of Takayasu arteritis. Materials and methods We used infliximab at an initial …

The objective of this study was to report the long-term use of tumor necrosis factor (TNF)
inhibitors in case series of patients with Takayasu's arteritis refractory to standard …

Objective. To analyse the efficacy and tolerance of infliximab in refractory Takayasu arteritis
(TA). Methods. French multicentre retrospective study that included patients with TA. Clinical …

Takayasu arteritis (TA) is a chronic vasculitis of unknown etiology. Experience with anti-
tumor necrosis factor alpha (anti-TNF) agents in difficult-to-treat patients with TA is limited …

Takayasu's arteritis (TA) is a rare granulomatous vasculitic disease that affects the aorta and
its major branches. Recent studies have suggested that anti-TNFα biological therapies are …

Takayasu's arteritis (TAK) is an idiopathic large-vessel vasculitis that usually affects young
females (1). Glucocorticoids are the mainstay of treatment for TAK, although relapses occur …

Takayasu arteritis (TA) is a rare large vessels vasculitis. Conventional therapy consists of
glucocorticoids which may be associated with other immunosuppressive drugs. However …